327 related articles for article (PubMed ID: 22724004)
1. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.
Palmer CN; Maglio C; Pirazzi C; Burza MA; Adiels M; Burch L; Donnelly LA; Colhoun H; Doney AS; Dillon JF; Pearson ER; McCarthy M; Hattersley AT; Frayling T; Morris AD; Peltonen M; Svensson PA; Jacobson P; Borén J; Sjöström L; Carlsson LM; Romeo S
PLoS One; 2012; 7(6):e39362. PubMed ID: 22724004
[TBL] [Abstract][Full Text] [Related]
2. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals.
Burza MA; Pirazzi C; Maglio C; Sjöholm K; Mancina RM; Svensson PA; Jacobson P; Adiels M; Baroni MG; Borén J; Ginanni Corradini S; Montalcini T; Sjöström L; Carlsson LM; Romeo S
Dig Liver Dis; 2012 Dec; 44(12):1037-41. PubMed ID: 22704398
[TBL] [Abstract][Full Text] [Related]
3. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
Pirazzi C; Adiels M; Burza MA; Mancina RM; Levin M; Ståhlman M; Taskinen MR; Orho-Melander M; Perman J; Pujia A; Andersson L; Maglio C; Montalcini T; Wiklund O; Borén J; Romeo S
J Hepatol; 2012 Dec; 57(6):1276-82. PubMed ID: 22878467
[TBL] [Abstract][Full Text] [Related]
4. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.
Romeo S; Sentinelli F; Cambuli VM; Incani M; Congiu T; Matta V; Pilia S; Huang-Doran I; Cossu E; Loche S; Baroni MG
J Hepatol; 2010 Aug; 53(2):335-8. PubMed ID: 20546964
[TBL] [Abstract][Full Text] [Related]
5. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.
Valenti L; Rametta R; Ruscica M; Dongiovanni P; Steffani L; Motta BM; Canavesi E; Fracanzani AL; Mozzi E; Roviaro G; Magni P; Fargion S
BMC Gastroenterol; 2012 Aug; 12():111. PubMed ID: 22898488
[TBL] [Abstract][Full Text] [Related]
6. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
[TBL] [Abstract][Full Text] [Related]
7. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
[TBL] [Abstract][Full Text] [Related]
8. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.
Viganò M; Valenti L; Lampertico P; Facchetti F; Motta BM; D'Ambrosio R; Romagnoli S; Dongiovanni P; Donati B; Fargion S; Colombo M
Hepatology; 2013 Oct; 58(4):1245-52. PubMed ID: 23564580
[TBL] [Abstract][Full Text] [Related]
9. Associations of I148M variant in PNPLA3 gene with plasma ALT levels during 2-year follow-up in normal weight and overweight children: the PANIC Study.
Viitasalo A; Pihlajamaki J; Lindi V; Atalay M; Kaminska D; Joro R; Lakka TA
Pediatr Obes; 2015 Apr; 10(2):84-90. PubMed ID: 24916969
[TBL] [Abstract][Full Text] [Related]
10. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent.
Romeo S; Sentinelli F; Dash S; Yeo GS; Savage DB; Leonetti F; Capoccia D; Incani M; Maglio C; Iacovino M; O'Rahilly S; Baroni MG
Int J Obes (Lond); 2010 Jan; 34(1):190-4. PubMed ID: 19844213
[TBL] [Abstract][Full Text] [Related]
11. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
[TBL] [Abstract][Full Text] [Related]
12. Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.
Ericson E; Bergenholm L; Andréasson AC; Dix CI; Knöchel J; Hansson SF; Lee R; Schumi J; Antonsson M; Fjellström O; Nasr P; Liljeblad M; Carlsson B; Kechagias S; Lindén D; Ekstedt M
Hepatol Commun; 2022 Oct; 6(10):2689-2701. PubMed ID: 35833455
[TBL] [Abstract][Full Text] [Related]
13. The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.
Luukkonen PK; Qadri S; Lehtimäki TE; Juuti A; Sammalkorpi H; Penttilä AK; Hakkarainen A; Orho-Melander M; Arola J; Yki-Järvinen H
J Clin Endocrinol Metab; 2021 Jan; 106(1):e300-e315. PubMed ID: 33064150
[TBL] [Abstract][Full Text] [Related]
14. PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity.
Mondul A; Mancina RM; Merlo A; Dongiovanni P; Rametta R; Montalcini T; Valenti L; Albanes D; Romeo S
J Nutr; 2015 Aug; 145(8):1687-91. PubMed ID: 26136587
[TBL] [Abstract][Full Text] [Related]
15. The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat.
Giudice EM; Grandone A; Cirillo G; Santoro N; Amato A; Brienza C; Savarese P; Marzuillo P; Perrone L
PLoS One; 2011; 6(11):e27933. PubMed ID: 22140488
[TBL] [Abstract][Full Text] [Related]
16. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
Hyysalo J; Gopalacharyulu P; Bian H; Hyötyläinen T; Leivonen M; Jaser N; Juuti A; Honka MJ; Nuutila P; Olkkonen VM; Oresic M; Yki-Järvinen H
Diabetes; 2014 Jan; 63(1):312-22. PubMed ID: 24009255
[TBL] [Abstract][Full Text] [Related]
17. Interaction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.
De Nicola S; Dongiovanni P; Aghemo A; Cheroni C; D'Ambrosio R; Pedrazzini M; Marabita F; Donnici L; Maggioni M; Fargion S; Colombo M; De Francesco R; Valenti L
PLoS One; 2014; 9(8):e106022. PubMed ID: 25171251
[TBL] [Abstract][Full Text] [Related]
18. PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations.
Larrieta-Carrasco E; Acuña-Alonzo V; Velázquez-Cruz R; Barquera-Lozano R; León-Mimila P; Villamil-Ramírez H; Menjivar M; Romero-Hidalgo S; Méndez-Sánchez N; Cárdenas V; Bañuelos-Moreno M; Flores YN; Quiterio M; Salmerón J; Sánchez-Muñoz F; Villarreal-Molina T; Aguilar-Salinas CA; Canizales-Quinteros S
Mol Biol Rep; 2014 Jul; 41(7):4705-11. PubMed ID: 24691744
[TBL] [Abstract][Full Text] [Related]
19. PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.
Burza MA; Molinaro A; Attilia ML; Rotondo C; Attilia F; Ceccanti M; Ferri F; Maldarelli F; Maffongelli A; De Santis A; Attili AF; Romeo S; Ginanni Corradini S
Liver Int; 2014 Apr; 34(4):514-20. PubMed ID: 24102786
[TBL] [Abstract][Full Text] [Related]
20. The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro.
Pillai S; Duvvuru S; Bhatnagar P; Foster W; Farmen M; Shankar S; Harris C; Bastyr E; Hoogwerf B; Haupt A
Pharmacogenomics J; 2018 May; 18(3):487-493. PubMed ID: 29160303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
